Overexpression of lncRNA TUG1 enhances the efficacy of DC-CIK immunotherapy in neuroblastoma in vitro and in vivo
Cancer Biomarkers · 2023
DOI: 10.3233/cbm-210436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Biomarkers, 2023. Verfasst von Wei-Qiang Tan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Xiang'an Hospital of Xiamen University, Xiamen University, Xiamen, Fujian, China. Hauptthemen laut MEDLINE: Immunotherapy, Neuroblastoma, RNA, Long Noncoding, Dendritic Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Long non-coding RNA (LncRNA) TUG1 plays a critical role in the development of human cancers. This study explored whether TUG1 is involved in the cytotoxicity of dendritic cells and cytokine-induced killer cells (DCs-CIK), an immunotherapy approach, in neuroblastoma. METHODS: A TUG1 expression plasmid was transfected into DCs. Neuroblastoma SK-N-SH cells were incubated with CIK cells, DCs-CIK cells, and TUG1-overexpressing DCs-CIK cells, with or without irradiation. SK-N-SH cell viability, colony formation, migration, and apoptosis were analyzed using CCK-8, colony formation assay, transwell assay, and flow cytometry, respectively. Production of IL-12, IL-2 and IFN-γ in the supernatants was determined using ELISA. A dual luciferase activity assay was performed to confirm the molecular interactions between TUG1 and miR-204. Tumor-bearing mice were established by injection of SK-N-SH cells followed by stimulation with CIK cells, DC-CIK cells, and TUG1-overexpressing DCs-CIK cells. RESULTS: Compared to CIK alone or DC-CIK therapy, overexpression of TUG1 significantly suppressed tumor cell proliferation, colony formation, and migration of neuroblastoma cells. Moreover, upregulation of TUG1 robustly induced apoptosis and altered key molecules associated with apoptosis and epithelial-mesenchymal transition. Contents of IL-12, IL-2 and IFN-γ were dramatically elevated in the supernatants in the coculturing system upon transfection with TUG1. In addition, TUG1 was found to be act as miR-204 sponge. Furthermore, in vivo experiments demonstrated that upregulation of TUG1 potentiated the antitumor activity of DC-CIK immunotherapy. CONCLUSION: Overexpression of TUG1 promotes DC maturation and enhances CIK cytotoxicity, suggesting that TUG1 may be a novel target for enhancing DC-CIK based immunotherapy for neuroblastoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Xiang'an Hospital of Xiamen University, Xiamen University, Xiamen, Fujian, China.
- Department of Surgery, Children's Hospital of Soochow University, Soochow University, Suzhou, Jiangsu, China.
Zitieren
APA
Tan, W. Q., Yuan, L., Cao, X., Wu, X. Y., Xing, Y. Q., & Ye, M. (2023). Overexpression of lncRNA TUG1 enhances the efficacy of DC-CIK immunotherapy in neuroblastoma in vitro and in vivo. Cancer Biomarkers. https://doi.org/10.3233/cbm-210436
Vancouver
Tan WQ, Yuan L, Cao X, Wu XY, Xing YQ, Ye M. Overexpression of lncRNA TUG1 enhances the efficacy of DC-CIK immunotherapy in neuroblastoma in vitro and in vivo. Cancer Biomarkers. 2023. doi:10.3233/cbm-210436
BibTeX
@article{Tan2023,
author = {Tan, Wei-Qiang and Yuan, Li and Cao, Xu and Wu, Xiao-Yuan and Xing, Yi-Qun and Ye, Ming},
title = {Overexpression of lncRNA TUG1 enhances the efficacy of DC-CIK immunotherapy in neuroblastoma in vitro and in vivo},
journal = {Cancer Biomarkers},
year = {2023},
doi = {10.3233/cbm-210436}
}
EUVIMED